“Everyone is doing sequencing, but most people aren’t able to analyze their sequences as well or as quickly as they might want to,” Bedford said. “We’re trying to fill in this gap so that the World Health Organization or the U.S. Centers for Disease Control and Prevention — or whoever — can have better analysis tools to do what they do. We’re hoping that will get our software in the hands of a lot of people”...
U.S. Food and Drug Administration (FDA)
See the following -
New Smartphone App Promises Easy Eye Testing Worldwide
The team behind a smartphone-based portable eye examination kit have just launched a crowdfunding campaign to raise money for new innovation...
- Login to post comments
New Trends and Troubles for AI in Medicine
Medicine is a complex field. So complex that any given person can’t know more than a fraction of what’s going on. Keeping up with the latest discoveries is impossible. Machine learning and other forms of artificial intelligence offer a new way of looking at medicine and a great power to automate medical tasks. At the South by Southwest conference event in Austin, TX, a panel of experts came together to discuss the state of medical AI and how machine learning can benefit both patients and doctors...
- Login to post comments
RNs Urge Tougher Federal Oversight On Unproven Medical Technology On which Hospitals Spend Billions
National Nurses United is calling on the U.S. Food and Drug Administration to enact meaningful oversight and public protections on the use of unproven medical technology that is rapidly spreading through the nation’s healthcare system...
- Login to post comments
Sciedu Press: Open Access - The Trend Of Scholarly Publishing
Sciedu Press is a scientific publishing house and completely private. They publish various researches from around the globe in the fields of education, science, and culture, which include educational and scientific books along with scholarly journals. Sciedu Press specializes in research journal publications covering fields pertaining to medicine, sciences, engineering, social sciences, management, and business...
- Login to post comments
Seattle’s Health Innovators of the Year: Industry Group Recognizes 7 Leaders in the Field
Washington’s life sciences industry has a habit of flying under the radar, despite the innovative and impactful work being done in labs and clinics around the state every day. But once a year, the Seattle Health Innovation Forum brings this work to the top by recognizing local leaders in health innovation, from researchers to startup mentors to those changing the way we communicate about health. The 2016 Health Innovator of the Year awardees include Ingrid Swanson Pultz, a senior research fellow at the University of Washington’s Institute for Protein Design and the Chief Scientific Officer at PvP Biologics. She received the Imagination Award, which recognizes imaginative problem-solving in the health sciences...
- Login to post comments
Study Unveils New Way to Starve Tumors to Death
For decades, scientists have tried to halt cancer by blocking nutrients from reaching tumor cells, in essence starving tumor cells of the fuel needed to grow and proliferate. Such attempts often have disappointed because cancer cells are nimble, relying on numerous backup routes to continue growing. Now, scientists at Washington University School of Medicine in St. Louis have exploited a common weak point in cancer cell metabolism, forcing tumor cells to reveal the backup fuel supply routes they rely on when this weak point is compromised. Mapping these secondary routes, the researchers also identified drugs that block them. They now are planning a small clinical trial in cancer patients to evaluate this treatment strategy...
- Login to post comments
The Data You've Been Missing — Provided by Patients
Ask orthopedic surgeon Andrew Jawa, M.D., when his total shoulder replacement patients can expect to put on a jacket without help. His answer is likely to include the exact postoperative week — with evidence-based variations due to each patient's age and condition. Jawa performs more than 220 total shoulder replacements each year at the Boston Sports and Shoulder Center. And his success relies in part on self-reported data provided by his patients at every visit, from the first preoperative appointment through every follow-up visit for the next five years...
- Login to post comments
The Rise of 'Technology-Enabled' Clinical Research Companies
Eric Hodgins, senior vice president, research and development technology solutions at QuintilesIMS, told us there are a number of dynamics “significantly transforming the industry and driving an increase in technology-enabled clinical research.” Notably, there are two macro trends: the pace of innovation in scientific research and the explosion of technological advancements...
- Login to post comments
The Story of How Fake Sugar Got Approved is Scary As Hell
The common-sense wisdom about the most widespread artificial sweetener on the market, aspartame, is that it's perfectly safe. The substance laces more than 6,000 products and is added to diet versions of Coke, Pepsi, Sprite, and Dr. Pepper. It is also sold under the brand names NutraSweet and Equal. It represents a multi-billion-dollar industry. Popular pieces across the internet in recent years have declared that concerns about aspartame are just a bunch of hype. A pediatrician and writer for The New York Times defends aspartame and says he regularly gives it to his kids. Vox dismisses concerns about the sweetener and includes a video about how safe the stuff is...
- Login to post comments
The White House Is Pushing Precision Medicine, but It Won’t Happen for Years
For starters, it’s too expensive and the science isn’t advanced enough. With the right technologies to collect and make sense of biomedical information, we could speed up the pace of discoveries that lead to a new class of tailor-made drugs. That’s the argument behind the White House’s push for “precision medicine” (see “A Shot in the Arm for Obama’s Precision Medicine Initiative”). The goal of precision medicine is to provide drugs and therapies that are uniquely suited to individual patients based on their genetics and other distinguishing health information...
- Login to post comments
This Device Could Detect Dozens Of Cancers With A Single Blood Test
Early detection, we’re often told, is the surest way to beat cancer...Current diagnostic methods for other cancers are invasive and expensive, so the vast majority of cancer patients never realize they might have cancer until something goes wrong with their health...
- Login to post comments
Transparency Life Sciences Awarded $1.4 Million NCATS SBIR Grant To Conduct Innovative Trial Of Lisinopril In Multiple Sclerosis
Transparency Life Sciences, LLC (TLS)...today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive therapy for multiple sclerosis (MS).
- Login to post comments
U.S. Government Probes Medical Devices For Possible Cyber Flaws
The U.S. Department of Homeland Security is investigating about two dozen cases of suspected cybersecurity flaws in medical devices and hospital equipment that officials fear could be exploited by hackers, a senior official at the agency told Reuters...
- Login to post comments
U.S. Researchers, U.K. Partner On Open Data Healthcare Framework
The creation of a blueprint for the use of open data in healthcare was the driving force behind a recent collaboration between researchers at New York University's GovLab and England's National Health Service...
- Login to post comments